Researchers Develop AI Tool to Predict Barrett’s Esophagus Recurrence After Therapy
julia.milzer@ucdenver.edu (Julia Milzer)
A new artificial intelligence (AI)–based tool shows promise for improving surveillance in patients treated with endoscopic eradication therapies for Barrett’s esophagus (BE)-related dysplasia and early esophageal adenocarcinoma. BE is the only known condition that precedes esophageal adenocarcinoma – an aggressive cancer with high mortality rates.
Developed and validated by U.S. researchers, the AI model was over 90% accurate at predicting which patients would experience a recurrence of BE...